ANAB vs MGM · rev $234.6M vs P/E 64, rev $4.45B
AnaptysBio Inc (ANAB) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported MGM revenue for 2026-06-30 was $4.45B. Net income was $292.4M. Revenue was down 0.1% from 2026-03-31 to 2026-06-30. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
ANAB currently screens at market cap $1.62B. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the ANAB and MGM stock pages for the full models.
Not investment advice.